Monomorphic Epitheliotropic Intestinal T-cell Lymphoma

• CLINICAL_TRIALS research · 2026-04-17
  Clinical Trial Update: A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas [Phase 1, Phase 2]

  A study of DR-01 by Dren Bio is ongoing in Phase 1/Phase 2 to treat several T-cell and NK-cell lymphomas, with recruitment currently underwa…

• CLINICAL_TRIALS trial_result · 2026-04-02
  Clinical Trial Update: Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma [Phase 2]

  A Phase 2 trial evaluating adding duvelisib or CC-486 to standard therapy for several peripheral T-cell lymphomas has been suspended.

• CLINICAL_TRIALS withdrawal · 2026-04-01
  Clinical Trial Update: Tazemetostat Plus CHOP in 1L T-cell Lymphoma [Phase 2]

  A Phase 2 trial evaluating tazemetostat in combination with CHOP for first-line T-cell lymphomas has been withdrawn.

• CLINICAL_TRIALS research · 2026-03-31
  Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]

  Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.

• CLINICAL_TRIALS research · 2025-04-29
  Clinical Trial Update: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies [Phase 1]

  This clinical trial update describes a Phase 1 dose-escalation and dose-expansion study of anti-CD7 allogeneic CAR T-cells (WU-CART-007) in …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-08-27
  Clinical Trial Update: Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas [Phase 1, Phase 2]

  This clinical trial update covers a Phase 1/2 study of pembrolizumab plus pralatrexate in relapsed or refractory peripheral T-cell lymphomas…